Skip to main content
. Author manuscript; available in PMC: 2013 Jun 26.
Published in final edited form as: Curr Biomark Find. 2012 Jan 9;2012(2):1–6. doi: 10.2147/CBF.S27685

Figure 1.

Figure 1

Significant difference in CCL3L1 copy number in African-Americans compared with Caucasians.

Notes: The median CCL3L1 copy number among HIV-infected African-Americans and Caucasians stratified by severity of cognitive impairment using the Memorial Sloan Kettering score (MSK); MSK 0, cognitively normal; MSK 0.5, mild impairment; MSK 1–2, severe dementia.